Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
22 results
D1.182 - Investigation of risk factors for the development of food-induced enterocolitis syndrome in children with a history of allergic proctocolitis caused by milk
D1.184 - Evaluation of recombinant GAPDH for validation as a new apple allergen in the Mexican pediatric population
D1.185 - One-day oral challenge test in low risk nut allergic children
D1.186 - Reggsolving the eggnigma. Characteristics and prognosis of egg FPIES in children
D1.187 - The role of gut microbiota in non-specific lipid transfer protein (nsLTP) allergies: insights from 16S rRNA gene sequencing
D1.188 - Diet Diversity in Early Childhood, and Prevalence of Food Allergies in Children with Autism Spectrum Disorder
D1.189 - An Analysis of Adrenaline Auto-Injector distribution in the Republic of Ireland between 2019 to 2023
D1.191 - Global Survey on Healthcare Provider Practices in the Primary Prevention of Food Allergy: Implementation and Regional Gaps
D1.192 - Natural Course and Predictors of Cow’s Milk Allergy Resolution in an Asian Pediatric Cohort: Data from a Tertiary Care Center
D1.193 - Pumpkin Seed Allergy in Children
D1.194 - Phylogenetic relationships across allergenic foods to guide the risk assessment of novel food proteins
D1.195 - Immunoproteomic study of pear (Pyrus communis) in mexican population
D1.196 - Characterizing the detectable milk protein allergens in milk ladder foods
D1.197 - Casual consumption of small amounts of peanut in children with IgE-mediated allergy is associated with outgrowing IgE-mediated peanut allergy: results of a retrospective observational study
D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention
D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)
D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)
D3.392 - What information and education is crucial for people with food allergies?
D3.393 - Daily life with a peanut allergy, as a young adult- an interview study
D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download